The Effect Effect of Empagliflozin on Oxidative Stress in Patients With Type 2 Diabetes
Clinical trial NCT02890745 · COMPLETED
Trial details
- NCT number
- NCT02890745
- Sponsor
- Henrik Enghusen Poulsen
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-01
- Primary completion
- 2020-01-22
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.